KEYNOTE-177: Randomized phase III study of pembrolizumab versus investigator-choice chemotherapy for mismatch repair-deficient or microsatellite instability-high metastatic colorectal carcinoma.

Authors

null

Luis A. Diaz Jr.

Sidney Kimmel Cancer Center at Johns Hopkins University, Baltimore, MD

Luis A. Diaz Jr., Dung T. Le , Takayuki Yoshino , Thierry Andre , Johanna C. Bendell , Minori Koshiji , Yinghua Zhang , S. Peter Kang , Baohoang Lam , Dirk Jäger

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02563002

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract TPS815)

DOI

10.1200/JCO.2017.35.4_suppl.TPS815

Abstract #

TPS815

Poster Bd #

O15

Abstract Disclosures